首页> 美国卫生研究院文献>BMC Musculoskeletal Disorders >The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
【2h】

The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model

机译:应用褪黑激素拮抗剂(Luzindole)对提高双足大鼠脊柱侧弯模型成功率的价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAn ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzindole, the melatonin antagonist, in bipedal rat model, for the block of combination of melatonin and its receptor, to inhibit the melatonin effect, and then to understand whether this method can effectively improve the scoliosis rate of bipedal rat model, and investigate the role of melatonin in scoliosis. To investigate the feasibility of improving the success rate of bipedal rat scoliosis model via intraperitoneal injection of melatonin antagonist (Luzindole).
机译:背景技术理想的动物模型一直是研究青少年特发性脊柱侧凸(AIS)的发病机理和治疗方法的关键,而可用的方法却有明显的缺点。褪黑素的缺乏已被证明与AIS有关。在这项研究中,我们打算将褪黑激素拮抗剂Luzindole应用于两足动物模型中,以阻断褪黑激素及其受体的结合,从而抑制褪黑激素的作用,然后了解这种方法是否可以有效地提高脊柱侧凸的发生率。双足动物模型,并研究褪黑激素在脊柱侧弯的作用。为了探讨通过腹膜内注射褪黑激素拮抗剂(Luzindole)提高双足动物脊柱侧弯模型成功率的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号